Login / Signup

A phase 1 study of mebendazole with bevacizumab and irinotecan in high-grade gliomas.

Julie I KrystalDerek HansonDanielle DonnellyMark Atlas
Published in: Pediatric blood & cancer (2024)
Mebendazole was safe and well tolerated when administered with bevacizumab and irinotecan at doses up to 200 mg/kg/day. Further studies are needed to determine the efficacy of this treatment.
Keyphrases
  • high grade
  • low grade
  • metastatic colorectal cancer
  • randomized controlled trial
  • clinical trial
  • case control
  • combination therapy